A 3-antigen prophylactic hepatitis B virus vaccine confers rapid onset of protection in young adults, age 18-45, compared to a single-antigen hepatitis B virus vaccine

Conference: Annual Meeting of the European Association for the Study of the Liver (EASL) 2021
Date: June 23, 2021